The selective serotonin reuptake inhibitor fluoxetine reduces striatal in vivo levels of voltammetric nitric oxide (NO): A feature of its antidepressant activity?

Neuroscience Letters

Volumn 470, Issue 2, 2010, Pages 95-99

  Crespi, Francesco ^a  

^a GSK   (Italy)

Author keywords

Fluoxetine; In vivo voltammetry; Nitric oxide; Rat brain; Striatum

Indexed keywords

FLUOXETINE; N METHYL DEXTRO ASPARTIC ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

AMPEROMETRY; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ACTIVITY; IN VIVO STUDY; INHIBITION KINETICS; MALE; MICROELECTRODE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION;

ANESTHESIA; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CORPUS STRIATUM; ELECTROCHEMICAL TECHNIQUES; ELECTRODES, IMPLANTED; ENZYME INHIBITORS; FLUOXETINE; MALE; N-METHYLASPARTATE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; SEROTONIN UPTAKE INHIBITORS;

EID: 74449087607     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.12.049     Document Type: Article

References (34)

1. Archer S. Measurement of nitric oxide in biological models. FASEB J. 7 (1993) 349-360
2. Asada K., and Yoshikawa T. Frontiers of Reactive Oxygen Species in Biology and Medicine (1994), Elsevier, New York
3. Banke T.G., and Traynelis S.F. Activation of NR1/NR2B NMDA receptors. Nat. Neurosci. 6 (2003) 144-152
4. Beckman J.S., and Koppenol W.H. NO, superoxide and peroxynitrite: the good, the bad, the ugly. Am. J. Physiol. 271 (1996) 1424-1437
5. Bond A. Modern Polarographic Methods in Analytical Chemistry (1980), Dekker, New York
6. Bredt D.S., and Snyder S.H. Nitric oxide, a novel neuronal messenger. Neuron 8 (1992) 3-11
7. Crespi F. In vivo voltammetry detection of neuropeptides with micro carbon fibre biosensors: possibile selective detection of somatostatin. Anal. Biochem. 194 (1991) 1-8
8. Crespi F. Anxiolytics antagonize Yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety. J. Neurosci. Methods 180 (2009) 97-105
9. Crespi F., Campagnola M., Neudeck A., McMillan K., Rossetti Z., Pastorino A., Garbin U., Fratta-Pasini A., Reggiani A., Gaviraghi G., and Cominacini L. Can voltammetry measure nitrogen monoxide (NO) and/or nitrites?. J. Neurosci. Methods 109 (2001) 59-70
10. Crespi F., Lazzarini C., and Vecchiato E. E Voltammetric and functional evidence that NMDA and substance P mediate rat vascular relaxation via nitrogen monoxide (NO) release. Neurosci. Lett. 287 (2000) 219-222
11. Crespi F., Martin K., and Marsden C.A. Nafion coated carbon fibre electrodes combined with differential pulse voltammetry measure 5HT release in vivo. Neuroscience 27 (1988) 885-896
12. Crespi F., and Rossetti Z. Pulse of nitric oxide release in response to activation of N-methyl-d-aspartate receptors in the rat striatum: rapid desensitisation, inhibition by receptor antagonists and potentiation by glycine. J. Pharmacol. Exp. Ther. 309 (2004) 462-468
13. Crespi F., Vecchiato E., Lazzarini C., and Gaviraghi G. Electrochemical evidence that lacidipine stimulates release of nitrogen monoxide (NO) in rat aorta. Neurosci. Lett. 298 (2001) 171-174
14. Downard A.J., Roddick A., and Bond A.M. Covalent modification of carbon electrodes for voltammetric differentiation of dopamine and ascorbic acid. Anal. Chim. Acta 317 (1995) 303
15. Ford P.C., Wink D.A., and Stanbury D.M. Autoxidation kinetics of aqueous nitric oxide. FEBS Lett. 326 (1993) 1-3
16. Friedemann M.N., Robinson S.W., and Gerhardt G.A. O-phenylenediamine-modified carbon fiber electrodes for the detection of nitric oxide. Anal. Chem. 68 (1996) 2621-2628
17. Garthwaite J., and Boulton C.L. Nitric oxide signalling in the central nervous system. Annu. Rev. Physiol. 57 (1995) 683-706
18. Harkin A.J., Connor T.J., Walsh M., St John N., and Kelly J.P. Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors. Neuropharmacology 44 (2003) 616-623
19. Harvey B.H. Affective disorders and nitric oxide: a role in pathways to relapse and refractoriness?. Hum. Psychopharmacol. 11 (1996) 309-319
20. Joca S.R., and Guimaraes F.S. Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects. Psychopharmacology 185 (2006) 298-305
21. Luo D., Knezevich S., and Vincent S. NMDA induced NO release: an in vivo microdialysis study. Neuroscience 57 (1993) 897-900
22. Luo L., and Tan R.X. Fluoxetine inhibits dendrite atrophy of hippocampal neurons by decreasing nitric oxide synthase expression in rat depression model. Acta Pharmacol. Sin. 22 (2001) 865-870
23. Marcenac F., and Gonon F. Fast in vivo monitoring of dopamine release in the rat brain with differential pulse amperometry. Anal. Chem. 57 (1985) 1778-1779
24. Privat C., Lantoine F., Bedioui F., Millanvoye van Brussel E., Devynck J., and Devynck M.A. Nitric oxide production by endothelial cells: comparison of three methods of quantification. Life Sci. 61 (1997) 1193-1202
25. Rossetti Z.L., and Crespi F. Inhibition of nitric oxide release in vivo by ethanol alcoholism. Clin. Exp. Res. 28 (2004) 1746-1751
26. Self T., and Crespi F. Electron microscopic and voltammetric analysis of carbon fibre electrode pre-treatments. J. Mater. Med. 3 (1992) 418-425
27. Suzuki E., Yagi G., Nakaki T., Kanba S., and Asai M. Elevated plasma nitrate levels in depressive states. J. Affect. Disord. 63 (2001) 221-224
28. Ulak G., Mutlu O., Akar F.Y., and Erden F.I. Neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole augment the effects of antidepressants acting via serotonergic system in the forced swimming test in rats. Pharmacol. Biochem. Behav. 90 (2008) 563-568
29. Wobshall R., and Shain I. Effect of adsorbtion of electroactive species in stationary electrode polarography. Anal. Chem. 39 (1967) 1514
30. Wood J., and Garthwaite J. Models of the diffusional spread of nitric oxide: implications for neural NO signalling and its pharmacological properties. J. Neuropharmacol. 33 (1994) 1235-1244
31. Yanik M., Vural H., Kocyigit A., Tutkun H., Zoroglu S., Koylu A., and Akyol O. Is the arginine-nitric oxide pathway involved in the pathogenesis of schizophrenia?. Neuropsychobiology 47 (2003) 61-65
32. Yaron I., Skirazi I., Judovich R., Levartovsky D., Caspi D., and Yaron M. Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E-2, and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum. 42 (1999) 2561-2568
33. Yildiz F., Erden B.F., Ulak G., and Gacar N. Antidepressant like effect of 7-nitroindazole in the forced swimming test in rats. Psychopharmacology 149 (2000) 41-44
34. Zhou Q.G., Hu Y., Hua Y., Hu M., Luo C.X., Han X., and Zhu D.Y. Neuronal nitric oxide synthase contributes to chronic stress-induced depression by suppressing hippocampal neurogenesis. J. Neurochem. 103 (2007) 1843-1854